arrow
H

Herrero, Astrid

Montpellier University Hospital
H指数:0
被引数:4

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Do Trisectionectomies Improve Outcomes for Localized Bismuth-Corlette Type II and III Perihilar Cholangiocarcinoma? Insights From a Nationwide French Cohort Study

三切术是否能改善局限性Bismuth-Corlette II型和III型肝门部胆管癌的预后?——来自一项法国全国队列研究的见解

2025-08-010
PRE
Deep learning-based phenotyping reclassifies combined hepatocellular-cholangiocarcinoma
2023-12-1414
OAAI
Large, multifocal or portal vein-invading hepatocellular carcinoma (HCC) downstaged by Y90 using personalized dosimetry: safety, pathological results and outcomes after surgery

Y90使用个性化剂量测定法降低大型,多灶性或门静脉侵犯性肝细胞癌 (HCC) 的分期: 安全性,病理学结果和术后结局

2023-06-015
OAAI
Prognostication algorithm for non-cirrhotic non-B non-C hepatocellular carcinoma-a multicenter study under the aegis of the French Association of Hepato-Biliary Surgery and liver Transplantation
2023-04-013
OAAI
Nestin as a diagnostic and prognostic marker for combined hepatocellular-cholangiocarcinoma

巢蛋白作为肝细胞-胆管癌的诊断和预后标志物

2022-12-0119
OAAI
Benefit of a flash dose of corticosteroids in digestive surgical oncology: a multicenter, randomized, double blind, placebo-controlled trial (CORTIFRENCH)
2022-08-232
OAAI
Alcohol Consumption the Day of Liver Transplantation for Alcohol-Associated Liver Disease Does Not Affect Long-Term Survival: A Case-Control Study
2020-12-199
PREAI